Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;83(11):1039-1043.
doi: 10.1007/s40265-023-01904-6.

Tofersen: First Approval

Affiliations
Review

Tofersen: First Approval

Hannah A Blair. Drugs. 2023 Jul.

Abstract

Tofersen (Qalsody) is an antisense oligonucleotide being developed by Biogen for the treatment of amyotrophic lateral sclerosis (ALS). On 25 April 2023, tofersen was approved in the USA for the treatment of ALS in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene. This article summarizes the milestones in the development of tofersen leading to this first approval for ALS.

PubMed Disclaimer

References

    1. Chen JJ. Overview of current and emerging therapies for amytrophic lateral sclerosis. Am J Manag Care. 2020;26(9 Suppl):S191–7. - PubMed
    1. Mead RJ, Shan N, Reiser HJ, et al. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22(3):185–212. - DOI - PubMed
    1. de Courssou J-BB, Durr A, Adams D, et al. Antisense therapies in neurological diseases. Brain. 2022;145(3):816–31. - DOI
    1. Biogen MA Inc. QALSODY (tofersen) injection, for intrathecal use: US prescribing information. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215887s000lbl.pdf . Accessed 30 May 2023.
    1. Biogen IP. Biogen exercises option with Ionis to develop and commercialize investigational treatment BIIB067 for a subtype of familial amyotrophic lateral sclerosis (ALS) based on positive phase 1 data [media release]. 6 Dec 2018. http://www.biogen.com .

MeSH terms

LinkOut - more resources